<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Percentage-Change Approach to Clinical Significance in R</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Percentage-Change Approach to Clinical
Significance in R</h1>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>In this tutorial, we will explore the percentage-change approach to
clinical significance using R. The percentage-change approach is
centered around a predefined relative change, expressed in percent, that
needs to be achieved in order to inferr a clinically significant change.
If, for instance, the percentage-change cutoff is believed to be 30%,
and a patient demonstrated a score change of at least 30%, then this
change is believed to be clinically significant. We will be working with
the <code>antidepressants</code> and <code>claus_2020</code> datasets,
and the <code>cs_percentage()</code> function to demonstrate various
aspects of this approach.</p>
<div id="prerequisites" class="section level2">
<h2>Prerequisites</h2>
<p>Before we begin, ensure that you have the following prerequisites in
place:</p>
<ul>
<li>R installed on your computer.</li>
<li>Basic understanding of R programming concepts.</li>
</ul>
</div>
<div id="looking-at-the-datasets" class="section level2">
<h2>Looking at the Datasets</h2>
<p>First, let’s have a look at the datasets, which come with the
package.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(clinicalsignificance)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a></span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a>antidepressants</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a><span class="co">#&gt; # A tibble: 1,110 × 4</span></span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="co">#&gt;    patient condition measurement mom_di</span></span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a><span class="co">#&gt;    &lt;chr&gt;   &lt;fct&gt;     &lt;fct&gt;        &lt;dbl&gt;</span></span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a><span class="co">#&gt;  1 S001    Wait List Before          50</span></span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a><span class="co">#&gt;  2 S001    Wait List After           36</span></span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a><span class="co">#&gt;  3 S002    Wait List Before          40</span></span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a><span class="co">#&gt;  4 S002    Wait List After           32</span></span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a><span class="co">#&gt;  5 S003    Wait List Before          38</span></span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a><span class="co">#&gt;  6 S003    Wait List After           41</span></span>
<span id="cb1-13"><a href="#cb1-13" tabindex="-1"></a><span class="co">#&gt;  7 S004    Wait List Before          29</span></span>
<span id="cb1-14"><a href="#cb1-14" tabindex="-1"></a><span class="co">#&gt;  8 S004    Wait List After           44</span></span>
<span id="cb1-15"><a href="#cb1-15" tabindex="-1"></a><span class="co">#&gt;  9 S005    Wait List Before          37</span></span>
<span id="cb1-16"><a href="#cb1-16" tabindex="-1"></a><span class="co">#&gt; 10 S005    Wait List After           45</span></span>
<span id="cb1-17"><a href="#cb1-17" tabindex="-1"></a><span class="co">#&gt; # ℹ 1,100 more rows</span></span>
<span id="cb1-18"><a href="#cb1-18" tabindex="-1"></a>claus_2020</span>
<span id="cb1-19"><a href="#cb1-19" tabindex="-1"></a><span class="co">#&gt; # A tibble: 172 × 9</span></span>
<span id="cb1-20"><a href="#cb1-20" tabindex="-1"></a><span class="co">#&gt;       id   age sex    treatment  time   bdi shaps   who  hamd</span></span>
<span id="cb1-21"><a href="#cb1-21" tabindex="-1"></a><span class="co">#&gt;    &lt;dbl&gt; &lt;dbl&gt; &lt;fct&gt;  &lt;fct&gt;     &lt;dbl&gt; &lt;dbl&gt; &lt;dbl&gt; &lt;dbl&gt; &lt;dbl&gt;</span></span>
<span id="cb1-22"><a href="#cb1-22" tabindex="-1"></a><span class="co">#&gt;  1     1    54 Male   TAU           1    33     9     0    25</span></span>
<span id="cb1-23"><a href="#cb1-23" tabindex="-1"></a><span class="co">#&gt;  2     1    54 Male   TAU           2    28     6     3    17</span></span>
<span id="cb1-24"><a href="#cb1-24" tabindex="-1"></a><span class="co">#&gt;  3     1    54 Male   TAU           3    28     9     7    13</span></span>
<span id="cb1-25"><a href="#cb1-25" tabindex="-1"></a><span class="co">#&gt;  4     1    54 Male   TAU           4    27     8     3    13</span></span>
<span id="cb1-26"><a href="#cb1-26" tabindex="-1"></a><span class="co">#&gt;  5     2    52 Female PA            1    26    11     2    15</span></span>
<span id="cb1-27"><a href="#cb1-27" tabindex="-1"></a><span class="co">#&gt;  6     2    52 Female PA            2    26    10     0    16</span></span>
<span id="cb1-28"><a href="#cb1-28" tabindex="-1"></a><span class="co">#&gt;  7     2    52 Female PA            3    25    10     0     7</span></span>
<span id="cb1-29"><a href="#cb1-29" tabindex="-1"></a><span class="co">#&gt;  8     2    52 Female PA            4    19     9     3    11</span></span>
<span id="cb1-30"><a href="#cb1-30" tabindex="-1"></a><span class="co">#&gt;  9     3    54 Male   PA            1    15     2     0    28</span></span>
<span id="cb1-31"><a href="#cb1-31" tabindex="-1"></a><span class="co">#&gt; 10     3    54 Male   PA            2    13     5     9    17</span></span>
<span id="cb1-32"><a href="#cb1-32" tabindex="-1"></a><span class="co">#&gt; # ℹ 162 more rows</span></span></code></pre></div>
</div>
</div>
<div id="percentage-change-approach" class="section level1">
<h1>Percentage-Change Approach</h1>
<p>The <code>cs_percentage()</code> function is a tool for assessing
clinical significance. It allows you to determine if changes in patient
outcomes are practically significant. Let’s go through the basic usage
and some advanced features of this function.</p>
<div id="basic-analysis" class="section level2">
<h2>Basic Analysis</h2>
<p>Let’s start with a basic clinical significance distribution analysis
using the <code>antidepressants</code> dataset. We are interested in the
Mind over Mood Depression Inventory (<code>mom_di</code>) measurements
and want to set the percentage cutoff for an improvement to a value of
0.3.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a>pct_results <span class="ot">&lt;-</span> antidepressants <span class="sc">|&gt;</span> </span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>    <span class="at">id =</span> patient,</span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>    <span class="at">time =</span> measurement,</span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>    <span class="at">outcome =</span> mom_di,</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.3</span></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>  )</span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a><span class="co">#&gt; ℹ Your &quot;Before&quot; was set as pre measurement and and your &quot;After&quot; as post.</span></span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a><span class="co">#&gt; • If that is not correct, please specify the pre measurement with the argument</span></span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a><span class="co">#&gt;   &quot;pre&quot;.</span></span></code></pre></div>
</div>
<div id="handling-warnings" class="section level2">
<h2>Handling Warnings</h2>
<p>Sometimes, as in the example above, you may encounter warnings when
using this function. You can turn off the warning by explicitly
specifying the pre-measurement time point using the pre parameter. This
can be helpful when your data lacks clear pre-post measurement
labels.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="co"># Turning off the warning by specifying pre-measurement time</span></span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>pct_results <span class="ot">&lt;-</span> antidepressants <span class="sc">|&gt;</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a>    <span class="at">id =</span> patient,</span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a>    <span class="at">time =</span> measurement,</span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a>    <span class="at">outcome =</span> mom_di,</span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a>    <span class="at">pre =</span> <span class="st">&quot;Before&quot;</span>,</span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.5</span></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a>  )</span></code></pre></div>
<p>Here’s a breakdown of the code:</p>
<ul>
<li><code>patient</code>, <code>measurement</code>, and
<code>mom_di</code> represent the patient identifier, assessment time
points, and HAM-D scores, respectively.</li>
<li><code>pre</code> and <code>post</code> specify the time points for
the pre and post-assessment.</li>
<li><code>pct_improvement</code> sets the percentage change threshold
for improvement to 30%.</li>
</ul>
</div>
<div id="printing-and-summarizing-the-results" class="section level2">
<h2>Printing and Summarizing the Results</h2>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="co"># Print the results</span></span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>pct_results</span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a><span class="co">#&gt; Percentage-change approach with a 50% decrease in instrument scores indicating</span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a><span class="co">#&gt; a clinical significant improvement.</span></span>
<span id="cb4-8"><a href="#cb4-8" tabindex="-1"></a><span class="co">#&gt; Category     |   n | Percent</span></span>
<span id="cb4-9"><a href="#cb4-9" tabindex="-1"></a><span class="co">#&gt; ----------------------------</span></span>
<span id="cb4-10"><a href="#cb4-10" tabindex="-1"></a><span class="co">#&gt; Improved     | 155 |  27.93%</span></span>
<span id="cb4-11"><a href="#cb4-11" tabindex="-1"></a><span class="co">#&gt; Unchanged    | 366 |  65.95%</span></span>
<span id="cb4-12"><a href="#cb4-12" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  34 |   6.13%</span></span>
<span id="cb4-13"><a href="#cb4-13" tabindex="-1"></a></span>
<span id="cb4-14"><a href="#cb4-14" tabindex="-1"></a><span class="co"># Get a summary</span></span>
<span id="cb4-15"><a href="#cb4-15" tabindex="-1"></a><span class="fu">summary</span>(pct_results)</span>
<span id="cb4-16"><a href="#cb4-16" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-17"><a href="#cb4-17" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb4-18"><a href="#cb4-18" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-19"><a href="#cb4-19" tabindex="-1"></a><span class="co">#&gt; Percentage-change analysis of clinical significance with a 50% decrease in</span></span>
<span id="cb4-20"><a href="#cb4-20" tabindex="-1"></a><span class="co">#&gt; instrument scores indicating a clinical significant improvement.</span></span>
<span id="cb4-21"><a href="#cb4-21" tabindex="-1"></a><span class="co">#&gt; There were 555 participants in the whole dataset of which 555 (100%) could be</span></span>
<span id="cb4-22"><a href="#cb4-22" tabindex="-1"></a><span class="co">#&gt; included in the analysis.</span></span>
<span id="cb4-23"><a href="#cb4-23" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-24"><a href="#cb4-24" tabindex="-1"></a><span class="co">#&gt; ── Individual Level Results</span></span>
<span id="cb4-25"><a href="#cb4-25" tabindex="-1"></a><span class="co">#&gt; Category     |   n | Percent</span></span>
<span id="cb4-26"><a href="#cb4-26" tabindex="-1"></a><span class="co">#&gt; ----------------------------</span></span>
<span id="cb4-27"><a href="#cb4-27" tabindex="-1"></a><span class="co">#&gt; Improved     | 155 |  27.93%</span></span>
<span id="cb4-28"><a href="#cb4-28" tabindex="-1"></a><span class="co">#&gt; Unchanged    | 366 |  65.95%</span></span>
<span id="cb4-29"><a href="#cb4-29" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  34 |   6.13%</span></span></code></pre></div>
</div>
<div id="visualizing-the-results" class="section level2">
<h2>Visualizing the Results</h2>
<p>Visualizing the results can help you better understand the clinical
significance of changes in patient outcomes.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a><span class="co"># Plot the results</span></span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a><span class="fu">plot</span>(pct_results)</span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAMAAAAjXV6yAAAArlBMVEUAAAAAADoAAGYAOpAAZrYaGhozMzM6AAA6ADo6AGY6kNtNTU1NTW5NTY5NbqtNjshmAABmtv9uTU1uTW5uTY5ubo5ubqtuq+SOTU2OTW6OTY6Obk2ObquOyP+QOgCQkDqQ2/+rbk2rbm6rjk2r5OSr5P+2ZgC2///Ijk3I///W1tbbkDrb///kq27k///o6Ojr6+v/tmb/yI7/25D/5Kv//7b//8j//9v//+T///8dcXcdAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAQVklEQVR4nO2d6WLcthGAEcesWylJ7bSJ0ibrxkl8UZF3HcuW+P4v1uUBcC4cvEEs5oe4BLHgzLeDwUEIVFUWp6itFYhdMiCPZEAeyYA8kgF5JAPyyEBAJ1EsyYNyzJOlzlG65ei53mUJAPT46vqb11X15afr7z5cHqDCD+jdofrruw+Prw7V3T93BCjEen8WzccB6Mt/3+vD/b/f7wZQkHt4sxQBVez+x9/rKnb/44fqy3/OVa3621ns/haLHOeQ4njU5TkAfX+o6ZxrWQeolvG/7DpZqqD645OiDAnSnev0HrQHQIER2MMnrBX78ktDZl8xaA5ARWgz/66pYo+vbvbTioW24W4+oYDOHaBv3++qHxTcyXHzCQUkyVjbdgOo0FlSBOR3Dy+gwmRJEJDfPbyAij5LBmTnkyggr3t4ARUwS3KAvO7hBVSgLBmQnU+SgHzu4QVUkCyJAfK5hxdQQbNkQHY+CQIi1iulhgEqeJakABHrlXIREgAVQpYMyM4nOUDU+oGAGJ/UAHHrB8Ugzid9QE4hWQQ+iQFyuocXkMQnHUDnqgT41BVrKCCRTzKAcDBuzgYCkvlkQB4+OwFU1x9XFqWmArLx2Qegxl5HFspneAyy8kkIkMM9vIDsfDIgD599AAqJQXb38AJy8dkJIH8Wu3t4ATn5pALI7h5e6918EgbkHKX21nv4JAJI5uMndPTymQIoHpFWzrV9xYD1dQGi77NbD5J++SAP8vpPGlVMtiyEz3wLyWMG5DLNzWfGlfYpAirm/FeEiAE5TXPUtKK8DEBu0+yx2qyvy4BEQP36usQBeUyzAQLr69IG1BtSc8AsUAzClwqU5SIAKS0UELjM+KQPiBAIBFSIWfYLSJgt67JQAmGACjnLbgFJ8612QMQ0eJ3zSR0QAUBbq8D1dekCQnaEAuLr63YHqMYhPBW0Aurad96cM+tZJdwloMYI4akge+yDrNaGQwTUel+YSgyQti0DIoD0ybGrTU5ACEcigDwxyFh51MYqNMZAMQjz4Hz2CcidhQNymCYA4tZnQJ0UiQHiYRkSIk02s1y1y18gH2lykYapHQGSGi4jtLow32gSghYgBvjhRQCyLkBMC1CXVNIWCTZoIqAC1iRHQ7cjQFIM6qD1CBAP6EgEUFHyzNr6vcYgSSAg1Ip5ABWlA5BP9gdIKx4MqCjTB9TVN8CnDR+6tVdwKE/Stf/IMSgNQDBiI9sUEO0b8IR6lmT9XIDqDd622v0FAMK2xQTo7vpQbbULnrYVAFJMNgZ0/8PPh812wTPGWvigGEQAmfRlAT3+9serw2a74BkSeIGdEtfYdem2y2PE6GFX8e6mrl5b7YKnoDsgDxJ+cm+9WsKDmv3LoAetC6hp37G9Yv1BIAP4zAfo7rqWm413wcOKc0/BbhW6AHEWQFXbzG+8C94gQMELEOcEtEE/SPVjVkjBCahr1qTnYgsC4rIGoLZxZ3wa81X/VIMCapswzielKVc/IGb2ZQOCVl48IBB4EB8FZut1FYPPxVAMUqj5B4f9AwL1yghzAWE+yPLJ0XVMBxC1OQPCgCgHeTRfsk/gRALE6xxPjxEQn7Bnirv4KHxZeOgBC5H54EnH6ADRLFYbAB0O6OioW2kBstuQAYF5emyMgg07ssy06EeTEBJrbOmRA+rtxz+3mF5gz8Kz1iKJnbZiIwGB51+7B6SkhQkg0QbIVBdwpnMUgIYAiCFS0oA/EkCNvgIfk4hiEHQaYypmIfFhgIQ2PgFAzCZt6RGbXpQOQJZO4iUBKqi37BuQNQbp9EonYGUVG813Z0oYzbv+oU6noOUvOIs+i6oVM4Qqc0Z/UIPA7R/aNGtnUGfpr+OcvacmAEhav5oiIGXqmPkLbcMBRtt2ln79mIJfAUkoBX7aFSDEpz4KGkNAPR8Eg9qLqFAWu4pBGs8gQGj9qgiIXObu4REboM/PX9SHj0/exg0Iru9NHBBo+1W7VhN7f2e8ZmCaeZZF9Q07AGYAwsTRgG7NrZ6uVsUQKbS1rzjiPOLE7lOfhtzNVtB0D3LJsoCgkjECCpDpgJS9Q60bIKW4pSydA2JfA7kwIPJbsAQroLMLfX6uHCFoOqBGVScfwVI8rLcSIF8jzHvrIS7oihDQSQT05ml1++TtrSMGTZZGFzkRLrOrBS6pA4lHutRO+I5yLshjF1gC1A18PjvQw8uny7Zidg+yrvHlgQT/4ggQjUhSgPF5UKOtBdDn51cLN/OMj2qX2impoe4PIL0/IEJgqI6/zQC5Y1CnrQTo4eXVx69+rSvagoCodC4l/tzQFRQcalD/MCcDB6tcjLYSoOrTs3Mf6M3Xf14sIKCtCMgvGwBySdnVDnRCR/MYpAMQ0jYaQHyMMYCQhoG9CgAAJPWZ7R/qiLYyoGa4cbUuoFpa15eEskCfxgJyeY8T0G3dftUN2aUBErSVAC07mlf2f4ovGSBF23dwVqLOsSIjFOtoXmfmgER7VgfUKCrzAQ0QNMsc+g3sqDcwPztKPoMzU0AWe1avYuMBgQ3s5gdktUcEtGSQHg5IYVvlNo2kewAphR+dWbXdopmX+dhjECMk8aHTHQYQKKg/dFn0J5e2EfWDTP3BoYFXDicgYz3CUwpljgf0RjmnghYCZLQXAcHng1sDqsdgtz5CswPqtRf+iwDsb6Ok0byCMYiP5kVCzX1ohRfOGKCHly+6P3EAEtwD+Q3PjN3D4kT1fZgS2J/aMwao6QQ9vHQ1YQsAQoqvA0hQJVJAxIojqk4B41TQocbpNAsUPLnJAenvRgCI/s5kibMPEBqSEXIkC8TTqwKo9KwMn10CokvwrIBYDe3xyICwUnIr9vm5ucU6j57dgIrZAVFVhgIKkwmAmDqYD14kX4gDdLoED7GRewH6JoKyAh/dxG8BiP9gpHWBw6hCdgM2WHWI6D1hykYCqLQD0uP3mQANVTZCQErh9XVOQIPkjEe1D96AssoxzNgMENWK8NGT6b2LzAKohPvsWH+rOABhKSVAtN8SAsgy3aHxZEAuQKf9AiIBWpGZPv2pY6DoqB0cUDruKyjz1J+s6PfwiQAQ59N5UIHTjJdQf8KeBQergpMp8+g2TNlQQPffX18vtPuLDZCwvjdeQPW2U/f/er3ELnilBVDB2WgIBAu5LFMZDEiB/6vxA/qrpvLusMAOVJSPjkGMT9/uu2EIaSd8Rqy38ukZBlSx1osW2AXPsu+cfkGstgqujlN9onSgeMyt8JlHxMyeHahuFtgFjztQieJz7yw88JA5RtvcCHeKEGUHe9CXn26q+XfBs/Hpp1wBDTpp31+2jeZ1VSIVK0hZNSgGnVuxQ01p7hhk8x/pySrJRDZYYm5DPw70IJTFD6jlM/sueNb6tTtA7T6Kh5n7QVY+tmfzoFKhCTMuHBA4b0UpNWNHUZJlAPEXxCJC5pNzNH/Cwy6JUPMxbkB2PtIKs1BA+i44AfrSXgA5+GRANkC2F8Qq1rBLk/YACj6caEvfXcPKYsCbA3LxER89K4X6i2irUlEqYzXVwCRWNJFn3gqQk08GZNt2Sx/ov2v3Qs+dckINWEdhH4BkPsYj2D/8w9H8IELCmW26Q+SzESCpfjkBkU+IJvnxRwOy2xMDoMLtQRcGSOLjjEE8Sqn2QY4yoUWZwbtizXyPTzzsABB9P5rz37Vb7zkaMKZgQKO9D3YfJrb0zQF5+QQAOgmNeCqAmPWMj65DKMEKCNatJAFJfFpBCei6vg8moGgEdvKJNQbR+sPfz+gGRO7DEEBAPi+JsRWjAUZ4f6ULELtP6oDE93viGNTDUqB1hlUMHzQRk4P0kUEpEQIqMSDr+0+5P+FuIQrSXJAm2MdgKfEBItZb+MiAcD/4IgDZ+IiAThSQlY4yCJUwoo8aELbeykectD/hyYoKmi0S6ldHMUKnU5wxCFtv5yNOmJlSICCSaD5hQDRLkLKbA3LwwYDkEUWKgJD1Lj4QkLYNmam6gQRJ7KuQMjEIVKj+C/pTBc/wYQNAyHonnx4QK8RYLM2W4njUh3HZB3UhOAv1s40AufloQEIhCQOS6o8TELDdCkgNlIgBIes9DtRsPYcAIEL9fYj1QwgBZdVCMWiYSAvsAl792omlUHa5O8PpMHGSDUt6EHQPn/+UtlECuw+7DOsJrVFCQfE089B8Hx9UCOPD6oPtslKTluBtB8jzglhWiN1FXA52MlOuPus9sg4g5D8uQEIhlwAI1y87ILEQGkwQGQYInFfkq7sARBcginhIIQIfQojyMZ0cGqcjBYT5WAAFKI6srESbCSD5q777sCwLAyJ8REBBiicPyLoAkdpoUxwaWclhBcUgy1ddyopZlgVE+Xi2nmsMDPEgexbBgxzWB2RZFBDj49l67mIByQsQLSbSQhScbm/PUgHE+QBAVhMrIe1EJu3l29tiUJCytiwLAhL4GEAOCy2A4Jnftj0BQuPTowPPUEBy4yRpMiXLcoAkPt3Wc1aR3ANz6GOQpXsjaDIpy2KARD7S1nNjbUsDEJ3/mU/xvQMS+cypuDMGKfQkbNJ9FgIk8Rmg1cQsukcU8XwQ5zNIq4lZ4gfE+AzUigqxdfeAKJ/BWhGhxnpLiT0GYT4jtCIyGFDkrRjiM4fiiQGCfGZSXElPvIILiW3CrOczWitZFJABhVjybwbI8PEp7tBKljQAaT5+xR1ayZIKoMKKZ2rwTCEGNXwCFV8wyxatWNDuLzWfdRRfoZBhgMJ2wSuLtRRf6z7BgIJ2oPLxSRlQ0C54ha+U/YoXkH8XvNLrPxfiQTKguv+zpuJr3ScYkDsGNeOvVRVf6z7BgFy74LXzP+sqvtZ9ggHZ+0Gl5rOo4rA7HCcgJH0hZc9nScXRgGpHgPS0WBH4zOLCAJWYTzyAAoazKwAqKZ9oYlDIhMjigErIZwVAQ7JEAKiU+GRAIqBiyGPBlfpB28cgxCc+QNu3YiKfDIgDwvPPMyrurCT7AUSeX8ynuDvM7gYQfb6TAWFA7PlXBoQA8eenOQZBQMLz5dyKAUDS8/cMyIjeHwCnzvLKn3gKQaXMsvNCPLZlQGsUkgENKWXRzU1SkAzIIxmQRzIgj2RAHpkOCD15HSXSC11HSL3Ua2ohj6+uv3mNSpkMCK9AGyPiC11HyN2Z8tRC3h3q9T6wlMmA8OqPMSK+0HW43P/w82GqNvXXK2zTZEB4/dBozeALXUfJ429/nH/3iYXc//h7XcVgKZMB4RVoI4W/0HWw3N3UFWNiIfWLL890YClReJDwQtcRajzO4UEfqDNHEIPEF7oOlfadnjdTY9AvDZlZYxBegTZGxBe6jtLkMLmQd4fWF2/ma8Wm94PEF7qOkDn6Qeevf/t+3n5Q6pIBeSQD8kgG5JEMyCMZkEdiBfTwsnlM/9WvWysSL6Cr+nD75O3GikQO6PPzFxsrEj+gT//4n3rytq5ym3hT5IDePHn76dnT+vT85/brP9dXJF5ATZA+O82nZ+da9rH2nk3qW7yArrpPn/5+bslu270FrpzfWUT2AmiL2tXITgB93KxDtBNADy/PLrQJpZ0AaoL2Jl4UK6BoJAPySAbkkQzIIxmQRzIgj2RAHsmAPJIBeSQD8sj/AbvUVJHBn4RnAAAAAElFTkSuQmCC" /><!-- --></p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a></span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a><span class="co"># Show clinical significance categories</span></span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a><span class="fu">plot</span>(pct_results, <span class="at">show =</span> category)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="data-with-more-than-two-measurements" class="section level2">
<h2>Data with More Than Two Measurements</h2>
<p>When working with data that has more than two measurements, you must
explicitly define the pre and post measurement time points using the
<code>pre</code> and <code>post</code> parameters.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="co"># Clinical significance distribution analysis with more than two measurements</span></span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a>cs_results <span class="ot">&lt;-</span> claus_2020 <span class="sc">|&gt;</span></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a>    id,</span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a>    time,</span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a>    bdi,</span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a>    <span class="at">pre =</span> <span class="dv">1</span>,</span>
<span id="cb7-8"><a href="#cb7-8" tabindex="-1"></a>    <span class="at">post =</span> <span class="dv">4</span>,</span>
<span id="cb7-9"><a href="#cb7-9" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.3</span></span>
<span id="cb7-10"><a href="#cb7-10" tabindex="-1"></a>  )</span>
<span id="cb7-11"><a href="#cb7-11" tabindex="-1"></a></span>
<span id="cb7-12"><a href="#cb7-12" tabindex="-1"></a><span class="co"># Display the results</span></span>
<span id="cb7-13"><a href="#cb7-13" tabindex="-1"></a>cs_results</span>
<span id="cb7-14"><a href="#cb7-14" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-15"><a href="#cb7-15" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb7-16"><a href="#cb7-16" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-17"><a href="#cb7-17" tabindex="-1"></a><span class="co">#&gt; Percentage-change approach with a 30% decrease in instrument scores indicating</span></span>
<span id="cb7-18"><a href="#cb7-18" tabindex="-1"></a><span class="co">#&gt; a clinical significant improvement.</span></span>
<span id="cb7-19"><a href="#cb7-19" tabindex="-1"></a><span class="co">#&gt; Category     |  n | Percent</span></span>
<span id="cb7-20"><a href="#cb7-20" tabindex="-1"></a><span class="co">#&gt; ---------------------------</span></span>
<span id="cb7-21"><a href="#cb7-21" tabindex="-1"></a><span class="co">#&gt; Improved     | 19 |  47.50%</span></span>
<span id="cb7-22"><a href="#cb7-22" tabindex="-1"></a><span class="co">#&gt; Unchanged    | 21 |  52.50%</span></span>
<span id="cb7-23"><a href="#cb7-23" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  0 |   0.00%</span></span>
<span id="cb7-24"><a href="#cb7-24" tabindex="-1"></a><span class="fu">summary</span>(cs_results)</span>
<span id="cb7-25"><a href="#cb7-25" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-26"><a href="#cb7-26" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb7-27"><a href="#cb7-27" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-28"><a href="#cb7-28" tabindex="-1"></a><span class="co">#&gt; Percentage-change analysis of clinical significance with a 30% decrease in</span></span>
<span id="cb7-29"><a href="#cb7-29" tabindex="-1"></a><span class="co">#&gt; instrument scores indicating a clinical significant improvement.</span></span>
<span id="cb7-30"><a href="#cb7-30" tabindex="-1"></a><span class="co">#&gt; There were 43 participants in the whole dataset of which 40 (93%) could be</span></span>
<span id="cb7-31"><a href="#cb7-31" tabindex="-1"></a><span class="co">#&gt; included in the analysis.</span></span>
<span id="cb7-32"><a href="#cb7-32" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-33"><a href="#cb7-33" tabindex="-1"></a><span class="co">#&gt; ── Individual Level Results</span></span>
<span id="cb7-34"><a href="#cb7-34" tabindex="-1"></a><span class="co">#&gt; Category     |  n | Percent</span></span>
<span id="cb7-35"><a href="#cb7-35" tabindex="-1"></a><span class="co">#&gt; ---------------------------</span></span>
<span id="cb7-36"><a href="#cb7-36" tabindex="-1"></a><span class="co">#&gt; Improved     | 19 |  47.50%</span></span>
<span id="cb7-37"><a href="#cb7-37" tabindex="-1"></a><span class="co">#&gt; Unchanged    | 21 |  52.50%</span></span>
<span id="cb7-38"><a href="#cb7-38" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  0 |   0.00%</span></span>
<span id="cb7-39"><a href="#cb7-39" tabindex="-1"></a><span class="fu">plot</span>(cs_results)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="setting-different-thresholds" class="section level2">
<h2>Setting Different Thresholds</h2>
<p>You can set different thresholds for improvement and deterioration by
adjusting the <code>pct_deterioration</code> argument Let’s see an
example:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a><span class="co"># Clinical significance analysis with different improvement and deterioration thresholds</span></span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>cs_results_2 <span class="ot">&lt;-</span> claus_2020 <span class="sc">|&gt;</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a>    <span class="at">id =</span> id,</span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>    <span class="at">time =</span> time,</span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>    <span class="at">outcome =</span> hamd,</span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a>    <span class="at">pre =</span> <span class="dv">1</span>,</span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a>    <span class="at">post =</span> <span class="dv">4</span>,</span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.3</span>,</span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a>    <span class="at">pct_deterioration =</span> <span class="fl">0.2</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a>  )</span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a><span class="co"># Display the results</span></span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a>cs_results_2</span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a><span class="co">#&gt; Percentage-change approach with a 30% decrease in instrument scores indicating</span></span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a><span class="co">#&gt; a clinical significant improvement and a 20% increase in instrument scores</span></span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a><span class="co">#&gt; indicating a clinical significant deterioration.</span></span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a><span class="co">#&gt; Category     |  n | Percent</span></span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a><span class="co">#&gt; ---------------------------</span></span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a><span class="co">#&gt; Improved     | 25 |  62.50%</span></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a><span class="co">#&gt; Unchanged    | 14 |  35.00%</span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  1 |   2.50%</span></span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a></span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a><span class="co"># Visualize the results</span></span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a><span class="fu">plot</span>(cs_results_2)</span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAMAAAAjXV6yAAAAn1BMVEUAAAAAADoAAGYAOpAAZrYaGhozMzM6AAA6ADo6AGY6kNtNTU1NTW5NTY5NbqtNjshmAABmtv9uTU1uTW5uTY5ubqtuq+SOTU2OTW6OTY6OyP+QOgCQkDqQ2/+rbk2ryKur5P+2ZgC2///Ijk3I///W1tbbkDrb///kq27k///o6Ojr6+v/tmb/yI7/25D/5Kv//7b//8j//9v//+T///9J5BAOAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAMBklEQVR4nO3dbWPTthYA4KyQcW/DdqG7g63dSym0Y5Q2tMv//22zHduxpfPmY9k6tnQ+wAiafM4TWU4qW2wOOcjYxE7AemQgJjIQExmIiQzERAZiYiDQPR7U3w1sNWVXt1B88V9KFQj0gYC2aQLBPgBQ45OBYKBtoqcY4uMBbROdgzAfF6jwSRII9XGASp8UgXCfPlDlkyAQ4dMDOvpkIAyo9kkPiPLpADU+yQGRPieg1ic1INqnBTr5JAbE+DRAHZ+0gDifGqjrk4F8oJ6PBOhht/vh0+Hw9H7349+LBmJ9KqC+jwBo//9Ph8//O/zzx2X529KANptN04j3KYEcH+EpViA9/fqpsloW0GZTCx0kPgWQ6yMEKobO/ue/D0+/XBd/+L4IsrWhqICq//oiiq33StsTcZT9xevrw8OPDVAZk77tAbtqRxDww1QgvPEjHUGFzGkELQmonYNEQFv9D+0/Xi5zDmoC+nE8MH5UQPW59c8f75Z4FTsGuF7h+yiXfT7vdsUctOTPQbcSoC3cSniKuTFDVeG6upUAbZFWCQDdSoC2WKsM1PFJEwgt3fdJEggv3fdJEYgo3fdJEIgq3ffJQIxPekBtmcVXMoFPckBdH0So55Ma0KlKFKjvkxhQp0oMyPFJC6hXpswnYSDwKub5JAXEl+77pATElw74OK2q83KlQPzYgHz6rY4z+zqBuLGB+CQDxJWO+WQgxieVOYgtHfNJ5CrGlo76pAHElo77JAHElk74pADElk75ZCDGJwEgrnTaZ/1AXOmMz+qBuNI5n7UDcaWzPqsGwtctmtJ5H6iPtQDh6xYNkMjH70MJZC6q4obdv+oF2Ed7gGH5hHnbgzSSjSB+/IQdQWGqCtLo2IpYO618RHe5rngOYmuX3Se93qsYUzh4g29KQKxP4kC8DzJDuS+vFEjkAwl5L68TSHADa9JAkhtYMxDtk/QcJLyBNdmrGF1765MsEF37ySdVILr2jk+iQHTtXZ8MxPikCUTW3vdJEois3fFRA90vF4is3fXRAt0vF4is3fPRAVU5LBSIrL3j03yZ0ADdrxWo73MUGg7U5LBMIPxt759feqA2h0UCoW+746MHOuWwRCD0bXd9tHNQN4cFAqFvu++DKDJAvRzWBYT5DAFyclgeEFE76jMAyM1hcUBE7biPGMjPYWlARO2EjxQIyGFhQETtlI8QCDjgwoCI2kkfERCY1WqAaB8JEJzVsoDw2hkfHgjLSgC0v9jtLk3sYYbXzvmwQGhWPFC5eeL+p2sDe7nWtQDLob4PvWbqLbTiWfFAD6WKhX0UT8W5C+qgD7Hq7v4tlZXgFDs4O3FG2ssVvxcVuIGVvunV+VvR4UmgcpPJ6Hu5ooPDHz+DRhCTlQTo6f27wyH2Xq698no+4PwrnoO4rARA+4vLUinuHAQhHH1kH5KRRnxWPNDR5xB3L1fCZwyQICse6POujMuon4MonxFAkqwEpxgUY0sfBkT6qIFkWS0aaIsPDh5ImBUE9O3N2/K3r2c3NoBoHx2QOKsFADE+KiB5Vj7Q3aaJlyZOMc5HAzQgK2IEUTG2dDkQ6zMcaFBWEJAgxpY+GujkMxhoWFYgUDGEvr3ZEFPQfEC8Dw3krKzW/4pE849JCLICgT68PNyd3dwZmIMEPiSQszZf/zsk9W9qoGIAPV+9tHAVk/jEAfr25twAkOj+1QFA94GAnq/Ov373e3mixQWS3b8qn4Pu28ln7Bz0+Kr4DPThxV8mgVwf6VVMmRUIxMfI0kWthPevCoG0WdkFgkv3fWSLpuqsYKDq68Z5VCC4dMBHtmhaHw+bfPCsQKC78vpVXsjiAcGlQz4CoPZ46OULzwoCMvBtHi4d9JEtmiYBBPtwQN3jBQKKf4qBpSM+NJBzvEBzUOxJGiwd8yGBxmcFA7GhLV3UCiwd9SGAQmRlEAgsHfeBgcqvGJ0+mVOLyAoA+rAhfxQ0NRBYOuEDAjmzMTc5E1n5QOV3sDtOSFW6rBVUOuUzN9Dz1dv6lzhAUOmkz9xA1Yeg5yvqEjYlEFQ67QMvmjogAeeguEBQ6YyPbNE03FUsKhBUOucjWzRdBxBUOusjWzQNCdSurM7+XQwonfeRLZoOyao3YXlAshhauqgVULrAR7ZoOiCr/iVPCTRF6DZgBTdeHRUVkP/qsE4Gjg1JK2BsSMZPZwQNOx7aKsgICpNKNyAf9ZO447KyOQdB40f9JG6wrOwAQT76J3FDZXVvBgj00T+JGyir6iUTQLCP/klc7njNLON+RbMKhPjon8Rljtdcp7wv+UaBMB8ZkPxmtTYWD7RtxobEZ/1AqI/+SVwuq0XNQbiP/knc8VmdXooNRPjon8QdnVXnpchAlA8DRB5wuh+5zgtE+sgWlcEDTrnsExWo5yNbVF41EO0jW1ReMxDjgwPxB1zFHMT56J/EHZOV+1I8INZH/yTuiKy8l6IB8T4gkPKAywcCfPRP4uqz8l+KBSTw0T+Jq84KeCkSkOj+TPWTuNqs7ADJ7s9UP4mrbGQHSHh/Zq/RqAMuGwjz0T+Jq2xkBqhfO+qjfxJX2cgKUL923GfT7vIztCplIyNA/cFB+tRCg6tSNrIB1D97cJ8WSFGVspEJoP70Qvg0QJqqlI3sAVE+3t3yygMOaGQBqCleuL+osiplIwNAndol969qq1I2UgNVu9+F2MOsOzh4H31VykZaoIfdD58OIfZy7Z09vI+qKvmeCrJWAqCPr/8sRlCAfRR7Zw/no6wK+/H89KdYgL1ch9y/qjrAAbtFNUCwQOP3cu2OD+7+TPXbbmEEKYF6PoOexB1UVYQ56Ag0dg7q+0z8JK6y0SigkXu5Oj4TP4mrbBTxc5DrI1s0HVIVcmo1L8Nd2bmBynMQLZoOAEIm5/ZlsCs7t+B5A0i2aJoMkO8j2744FSDAR7ZomsgcBPlM/CRuwK6mBwJ9Jn4SN2BXswKdfCZ+EjdgV5MDwT6yRdMAc5DT1SbMPooBgRCfiZ/ExbqqW6GN5wfCfGSLpusHQn0mfhIX68owkOMz8ZO4aFfG5iDcpwaiSoLz1bYyeRUjfCZ+EjdgVxMCUT4TP4kbsKvpgEgfzZO4o1rZ+y5G+yiexB3Xyt63edpn4vNC2CgmEOOTPBDpM64qXStjcxDrYwRI0GoSIN4nbSDKZ/KqoqysKoEIn8mA4qzNDwPCfYYmvE4g/AbfwQmvEgi/wXd4wmucg9AbfDUJr/Aqdovd4DtvVQG7mgbI9Zm7qoBdhQW6vQVv8J29qoBdBQW6PQJtWZ71A4EB38AaoGMLEWAEwZ9/orztAbsKDrQVLSqnCNSMHwtP4gbsKhhQe359EfAkCHSaf0SLykaA5vuJYmd+Fi0q2wCa72fS3euXaFE5SaD6+i5aVE4MqPf554uAxwjQXHNQ//OhhSdxA3YVAMj5/GyhqoBdjQdyfExUFbCr0UCuj4mqAnYVBGh74rFRVcCuxgJ5PiaqCtjVSKCuz9hUlI1MAwE+JqoK2NUoIMjHRFUBuxoD1PEJkYqykW0g3ydWVc23BtHK6jw3krc++qpCNDq2ar53itbm53kUAfHJQDVQ4zOmqiCNjAKhPnkOqgL3MXHpCdiVGmgL89ioKmBXSqBqfXnY/9IP3RZNEbua+99ZzUBMZCAmMtDaIgMxkYGYyEBMZCAm5gTy94zTdnSx212G6ephV25YS3Q1IxCwd64uyn0v9z9dh+iqfM+KPoiu5gOC9s7VxUNZysfLEF2VUfRBdDX3Kdbf+VQfRR+huiqGDtHV3ED9vXPVUe4PGqar/cXra6qrZY6gp/fvDjMNxrmBgkwc+4viGhamqzLI6WxuoP7eucp+Kp8gXdXnFtHVEj8Hfd6VcRnkc1DRVzEH2fgctMzIQExkICYyEBMZiIkMxIRVoOeraiH9u99jJ2IX6Lz87e7sJnIixoG+vXkbORH7QI///W1zdlOeclFGk3GgD2c3j69eln8sfrl78df8idgFqibpYtA8virOsq/l6IlyvtkFOq//6/E/xZXsruLanJP/zySxFKAYZ1cVCwH6Gu0D0UKAnq+KIRRFaSFA1aQdZRRZBTITGYiJDMREBmIiAzGRgZjIQExkICYyEBMZiIl/AdtFZc+RFdENAAAAAElFTkSuQmCC" /><!-- --></p>
</div>
<div id="grouped-analysis" class="section level2">
<h2>Grouped Analysis</h2>
<p>You can also perform a grouped analysis by providing a group column
from the data. This is useful when comparing treatment groups or other
categories.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a>cs_results_grouped <span class="ot">&lt;-</span> claus_2020 <span class="sc">|&gt;</span></span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a>    <span class="at">id =</span> id,</span>
<span id="cb9-4"><a href="#cb9-4" tabindex="-1"></a>    <span class="at">time =</span> time,</span>
<span id="cb9-5"><a href="#cb9-5" tabindex="-1"></a>    <span class="at">outcome =</span> hamd,</span>
<span id="cb9-6"><a href="#cb9-6" tabindex="-1"></a>    <span class="at">pre =</span> <span class="dv">1</span>,</span>
<span id="cb9-7"><a href="#cb9-7" tabindex="-1"></a>    <span class="at">post =</span> <span class="dv">4</span>,</span>
<span id="cb9-8"><a href="#cb9-8" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.3</span>,</span>
<span id="cb9-9"><a href="#cb9-9" tabindex="-1"></a>    <span class="at">group =</span> treatment</span>
<span id="cb9-10"><a href="#cb9-10" tabindex="-1"></a>  )</span>
<span id="cb9-11"><a href="#cb9-11" tabindex="-1"></a></span>
<span id="cb9-12"><a href="#cb9-12" tabindex="-1"></a><span class="co"># Display and visualize the results</span></span>
<span id="cb9-13"><a href="#cb9-13" tabindex="-1"></a>cs_results_grouped</span>
<span id="cb9-14"><a href="#cb9-14" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb9-15"><a href="#cb9-15" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb9-16"><a href="#cb9-16" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb9-17"><a href="#cb9-17" tabindex="-1"></a><span class="co">#&gt; Percentage-change approach with a 30% decrease in instrument scores indicating</span></span>
<span id="cb9-18"><a href="#cb9-18" tabindex="-1"></a><span class="co">#&gt; a clinical significant improvement.</span></span>
<span id="cb9-19"><a href="#cb9-19" tabindex="-1"></a><span class="co">#&gt; Group |     Category |  n | Percent</span></span>
<span id="cb9-20"><a href="#cb9-20" tabindex="-1"></a><span class="co">#&gt; -----------------------------------</span></span>
<span id="cb9-21"><a href="#cb9-21" tabindex="-1"></a><span class="co">#&gt; TAU   |     Improved |  6 |  15.00%</span></span>
<span id="cb9-22"><a href="#cb9-22" tabindex="-1"></a><span class="co">#&gt; TAU   |    Unchanged | 13 |  32.50%</span></span>
<span id="cb9-23"><a href="#cb9-23" tabindex="-1"></a><span class="co">#&gt; TAU   | Deteriorated |  0 |   0.00%</span></span>
<span id="cb9-24"><a href="#cb9-24" tabindex="-1"></a><span class="co">#&gt; PA    |     Improved | 19 |  47.50%</span></span>
<span id="cb9-25"><a href="#cb9-25" tabindex="-1"></a><span class="co">#&gt; PA    |    Unchanged |  2 |   5.00%</span></span>
<span id="cb9-26"><a href="#cb9-26" tabindex="-1"></a><span class="co">#&gt; PA    | Deteriorated |  0 |   0.00%</span></span>
<span id="cb9-27"><a href="#cb9-27" tabindex="-1"></a><span class="fu">plot</span>(cs_results_grouped)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="analyzing-positive-outcomes" class="section level2">
<h2>Analyzing Positive Outcomes</h2>
<p>In some cases, higher values of an outcome may be considered better.
You can specify this using the <code>better_is</code> argument. Let’s
see an example with the WHO-5 score where higher values are considered
better.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="co"># Clinical significance analysis for outcomes where higher values are better</span></span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>cs_results_who <span class="ot">&lt;-</span> claus_2020 <span class="sc">|&gt;</span></span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a>  <span class="fu">cs_percentage</span>(</span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a>    <span class="at">id =</span> id,</span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>    <span class="at">time =</span> time,</span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>    <span class="at">outcome =</span> who,</span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a>    <span class="at">pre =</span> <span class="dv">1</span>,</span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a>    <span class="at">post =</span> <span class="dv">4</span>,</span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a>    <span class="at">pct_improvement =</span> <span class="fl">0.3</span>,</span>
<span id="cb10-10"><a href="#cb10-10" tabindex="-1"></a>    <span class="at">better_is =</span> <span class="st">&quot;higher&quot;</span></span>
<span id="cb10-11"><a href="#cb10-11" tabindex="-1"></a>  )</span>
<span id="cb10-12"><a href="#cb10-12" tabindex="-1"></a></span>
<span id="cb10-13"><a href="#cb10-13" tabindex="-1"></a><span class="co"># Display the results</span></span>
<span id="cb10-14"><a href="#cb10-14" tabindex="-1"></a>cs_results_who</span>
<span id="cb10-15"><a href="#cb10-15" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-16"><a href="#cb10-16" tabindex="-1"></a><span class="co">#&gt; ── Clinical Significance Results ──</span></span>
<span id="cb10-17"><a href="#cb10-17" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-18"><a href="#cb10-18" tabindex="-1"></a><span class="co">#&gt; Percentage-change approach with a 30% increase in instrument scores indicating</span></span>
<span id="cb10-19"><a href="#cb10-19" tabindex="-1"></a><span class="co">#&gt; a clinical significant improvement.</span></span>
<span id="cb10-20"><a href="#cb10-20" tabindex="-1"></a><span class="co">#&gt; Category     |  n | Percent</span></span>
<span id="cb10-21"><a href="#cb10-21" tabindex="-1"></a><span class="co">#&gt; ---------------------------</span></span>
<span id="cb10-22"><a href="#cb10-22" tabindex="-1"></a><span class="co">#&gt; Improved     | 28 |  70.00%</span></span>
<span id="cb10-23"><a href="#cb10-23" tabindex="-1"></a><span class="co">#&gt; Unchanged    |  9 |  22.50%</span></span>
<span id="cb10-24"><a href="#cb10-24" tabindex="-1"></a><span class="co">#&gt; Deteriorated |  3 |   7.50%</span></span></code></pre></div>
</div>
</div>
<div id="conclusion" class="section level1">
<h1>Conclusion</h1>
<p>In this tutorial, you’ve learned how to perform clinical significance
analysis using the <code>cs_percentage()</code> function in R. This
analysis may be crucial for determining the practical importance of
changes in patient outcomes. By adjusting thresholds and considering
grouped analyses, you can gain valuable insights for healthcare and
clinical research applications.</p>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
